Table III.
The top 10 enriched pathways involved in development of lung adenocarcinoma.
| ID | Pathway name | P-value | P-adjust | Count |
|---|---|---|---|---|
| hsa05200 | Pathways in cancer | 1.28E-09 | 3.64E-07 | 152 |
| hsa04015 | Rap1 signaling pathway | 9.70E-07 | 9.21E-05 | 85 |
| hsa04020 | Calcium signaling pathway | 7.74E-07 | 9.21E-05 | 75 |
| hsa04921 | Oxytocin signaling pathway | 1.78E-06 | 0.000127156 | 67 |
| hsa04024 | cAMP signaling pathway | 2.75E-06 | 0.000156673 | 80 |
| hsa03008 | Ribosome biogenesis in eukaryotes | 6.25E-06 | 0.000296837 | 5 |
| hsa04010 | MAPK signaling pathway | 9.25E-06 | 0.000376788 | 96 |
| hsa00190 | Oxidative phosphorylation | 1.08E-05 | 0.000384468 | 13 |
| hsa04550 | Signaling pathways regulating pluripotency of stem cells | 1.34E-05 | 0.000423855 | 59 |
| hsa04022 | cGMP-PKG signaling pathway | 1.73E-05 | 0.000448535 | 54 |